Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)

Primary Objective:
- Assess the long term safety of sarilumab in patients with rheumatoid arthritis.

Secondary Objective:
- Assess the long term efficacy of sarilumab in patients with rheumatoid arthritis.


Study Type: Interventional
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Multi-center, Uncontrolled Extension Study Evaluating Efficacy and Safety of SAR153191 in Patients With Active Rheumatoid Arthritis (RA)
Estimated Enrollment: 2000
Study Start Date: June 2010
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)

Arms:
- Experimental: Extension study